First clinical results of fluorescence lifetime-enhanced tumor imaging using receptor targeted fluorescent probes

体内 荧光寿命成像显微镜 病理 荧光 癌症研究 癌症 分子成像 医学 帕尼单抗 分子探针
作者
Rahul Pal,Marisa Hom,Nynke S van den Berg,Thinzar Lwin,Yu-Jin Lee,Andrey Prilutskiy,William C. Faquin,Eric Yang,Srinivas Vinod Saladi,Mark A Varvares,Eben L. Rosenthal,Anand Kumar
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
标识
DOI:10.1158/1078-0432.ccr-21-3429
摘要

Fluorescence molecular imaging, using cancer-targeted near infrared (NIR) fluorescent probes, offers the promise of accurate tumor delineation during surgeries and the detection of cancer specific molecular expression in vivo. However, nonspecific probe accumulation in normal tissue results in poor tumor fluorescence contrast, precluding widespread clinical adoption of novel imaging agents. Here we present the first clinical evidence that fluorescence lifetime (FLT) imaging can provide tumor specificity at the cellular level in patients systemically injected with panitumumab-IRDye800CW, an EGFR-targeted NIR fluorescent probe.We performed wide-field and microscopic FLT imaging of resection specimens from patients injected with panitumumab-IRDye800CW under an FDA directed clinical trial.We show that the FLT within EGFR-overexpressing cancer cells is significantly longer than the FLT of normal tissue, providing high sensitivity (>98%) and specificity (>98%) for tumor versus normal tissue classification, despite the presence of significant nonspecific probe accumulation. We further show microscopic evidence that the mean tissue FLT is spatially correlated (r > 0.85) with tumor-specific EGFR expression in tissue and is consistent across multiple patients. These tumor cell-specific FLT changes can be detected through thick biological tissue, allowing highly specific tumor detection and noninvasive monitoring of tumor EFGR expression in vivo.Our data indicate that FLT imaging is a promising approach for enhancing tumor contrast using an antibody-targeted NIR probe with a proven safety profile in humans, suggesting a strong potential for clinical applications in image guided surgery, cancer diagnostics, and staging.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
火星上的帅哥完成签到,获得积分20
1秒前
王井彦发布了新的文献求助10
1秒前
臭小子发布了新的文献求助10
1秒前
务实问凝完成签到,获得积分20
2秒前
完美世界的应助被甜美紫真采纳,获得10
2秒前
111完成签到,获得积分10
2秒前
风吹麦浪的应助被Loooong采纳,获得10
2秒前
yan发布了新的文献求助10
2秒前
顾矜的应助被跑不掉的可乐猪采纳,获得10
2秒前
sfhklqwe发布了新的文献求助10
3秒前
jzmulyl发布了新的文献求助10
3秒前
3秒前
79999发布了新的文献求助10
3秒前
3秒前
彭于彦祖的应助被疯狂鱼博士采纳,获得30
4秒前
beginner发布了新的文献求助10
4秒前
Aspire发布了新的文献求助10
4秒前
角度更多完成签到,获得积分10
5秒前
gengssss完成签到,获得积分10
5秒前
6秒前
6秒前
6秒前
柯不惜发布了新的文献求助10
6秒前
你你你完成签到,获得积分10
7秒前
7秒前
7秒前
ZnCu完成签到 ,获得积分10
8秒前
LuoYR@SZU完成签到,获得积分10
8秒前
123发布了新的文献求助30
8秒前
脑洞疼的应助被624794951采纳,获得10
8秒前
8秒前
8秒前
乐乐的应助被刘智舰采纳,获得10
9秒前
9秒前
陈皮汤完成签到,获得积分10
9秒前
学术小张发布了新的文献求助10
9秒前
10秒前
乐乐的应助被一点点采纳,获得10
10秒前
Brad_AN发布了新的文献求助10
10秒前
ref:rain完成签到 ,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8162621
求助须知:如何正确求助?哪些是违规求助? 9556889
关于积分的说明 21737583
捐赠科研通 7753002
什么是DOI,文献DOI怎么找? 3427836
关于科研通互助平台的介绍 2552719
邀请新用户注册赠送积分活动 2472507